期刊文献+

重组人白细胞介素12的纯化与鉴定

Identification and purification of recombinant human interleukin-12
下载PDF
导出
摘要 目的探索重组人白细胞介素12(rhIL-12)的纯化与鉴定方法。方法采用Millipore超滤浓缩系统对含rhIL-12的无血清培养上清进行浓缩,用阴离子交换色谱柱,阳离子交换色谱柱和尺寸排阻色谱柱纯化出rhIL-12;并对rhIL-12的纯度、活性及氨基酸序列进行检测。结果纯化后产物经Western blot鉴定(P35、P40)为rhIL-12,毛细管电泳法测得其纯度在98%以上;生物学活性达8.0×106IU/mg,且氨基酸序列与已报道的序列相一致。结论建立了获得高纯度、高生物活性的rhIL-12的纯化与鉴定方法。 Purpose To explore the identification and purification methods of recombinmant human inter-leukin-12(rhIL-12). Methods The Millipore ultrafiltration standard system was used to concentrate rhIL-12, then anion exchange chromatographic column, cation exchange chromatographic column and size exclusive chromatographic column were used in turn to purify the target protein. Meanwhile, the purity, bio-activity and amino acid sequencing of target protein were tested. Results The product of purification was identified as rhIL- 12 by detecting P35 and P40 using Western blot. The protein purity which was identified by the capillary elec-trophoresis was above 98%. The biology activity was 8.0×10^6 IU/mg. The amino acids sequence was consistent with the predicted sequence. Conclusion The purification method that could obtain rhIL-12 owning high purification and biology activity has been established successfully.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2009年第1期14-17,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 国家863目标导向课题2006AA02Z491资助
关键词 重组人白细胞介素12 纯化 鉴定 human interleukin-12 purification identification
  • 相关文献

参考文献14

  • 1田瑞琴,何应.细胞因子类药物制剂研究进展[J].中国生化药物杂志,2005,26(5):315-317. 被引量:2
  • 2Zou J, Schoenhault D S, Catvajal D M, et al. Structure-function analysis of the p35 subunit of mouse inter leukin- 12 [ J ]. J Bio Chem, 1995,270 (11) :5864-5871.
  • 3Gillessen S, Carvajal D. Ling P, et al. Mouse interleukin-12 P40 homodimer: a potent IL-12 antagonis[ J]. Eur J Immunol, 1995,25 : 1-7.
  • 4Lamont A G, Adorini L. IL-12: a key eytokine in immune regulation [J]. Immunol Today, 1996,17(5) :214-217.
  • 5Matsunaga K, Yamaguchi H, Klein T W, et al. Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/ 44 mitogen-activated protein kinase cascade[J], Infect Immunol,2003, 71( 11 ) :6672-6675.
  • 6Little R F, Aleman K, Kumar P, et al. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma [ J]. Blood, 2007,110(13) :4165-4171.
  • 7Lenzi R,Edwards R,June C,et al.Phase Ⅱ study of intraperitoneal recombinant interleukin-12(rhIL-12) in patients with peritoneal carcinomatosis(residual disease < 1 cm)associated with ovarian cancer or primary peritoneal carcinoma[J] .Transl Med,2007,12(5):66-70.
  • 8Liu W,Wei H, Liang S, et al. A balanced expression of two chains of heterodimer protein, the human interleukin-12,improves high-level expression of the protein in CHO cells[J]. Biochem Biophys Res Commun, 2004,313 : 287-293.
  • 9Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning[ M]. A Laboratory Manual. 2nd ed. New York:Cold Spring Harbor Laboratory Press, 1989:38-718.
  • 10魏海明,田志刚.IL-12抗肿瘤作用研究现状[J].国外医学(肿瘤学分册),1997,24(3):155-157. 被引量:3

二级参考文献13

  • 1Reddy KR, Modi MW,Pedder S. Use of peginterferon alfa-2a (40 kD)(Pegasys) for the treatment of hepatitis C[J], Advanced Drug Delivery Reviews, 2002,54: 571-586.
  • 2Yukino Y, Masafumi T, Yoshiko F, et al. Potential usage of thermosensitive liposomes for site-specific delivery of cytokines[J]. Cancer Letters, 2000,155(1): 71-77.
  • 3Kedar E, Palgi O, Golod G, et al. Delivery of cytokines by liposomes.Ⅲ. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice[J]. J Immunother, 1997,20(3): 180-193.
  • 4Mandal B, Kempf M, Merkle HP, et al. Immobilisation of GM-CSF onto particulate vaccine carrier systems [ J ]. Int J Pharm, 2004, 269(1):259-265.
  • 5Lambert O, Nagele O, Loux V, et al. Poly (ethylene carbonate)microspheres: manufacturing process and internal structure characterization [ J ]. Journal of Controlled Release, 2000,67(1): 89-99.
  • 6Beilharz MW, Therapeutic potential for orally administered type 1 interferons [ J ], Pharmaceutical Science & Technology Today, 2000, 3(6): 193-197.
  • 7Rollwagen FM, Davis TA, Li YY, et al. Orally administered IL-6 induces elevated intestinal GM-CSF gene expression and splenic CFU-GM[J]. Cytokine ,2004,27(4-5): 107-113.
  • 8Kisel MA, Kulik LN, Tsybovsky IS, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studied in the rat[J] .Int J Phram,2001,216(1-2):105-114.
  • 9Senel S, Kremer MJ, Kas S, et al. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa [ J ]. Biomaterials, 2000,21(20):2067-2071.
  • 10Kumar M, Kong X, Behera AK, et al. Chitosan IFN-γ-pDNA nanoparticle (CIN) therapy for allergic asthma [ J ], Genet Vaccines Ther, 2003,1 (1):3-13.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部